New directions in whole blood analysis: Dried blood spot analysis and beyond

LCGC North America

Volumn 29, Issue 1, 2011, Pages 14-27

  Majors, Ronald E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79952786697     PISSN: 15275949     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ICH Harmonized Tripartate Guideline Code S3A 1994.
2. FDA Fed. Regist. 60, 11264 (1995).
3. I. Bang, Biochem. Ztschr. 49, 19-39 (1913).
4. R. Guthrie and A. Susi, Pediatrics 32, 338-343 (1963).
5. www.icadts2007.org/print/128bloodspotanalysis.pdf
6. C Bowen, Am. Lab. 42(10), 11-14, (2010).
7. C.A. Evans, "The Application of Dried Blood Spots for Quantitation of Xenobi-otics\A Paradigm Shift within Pre-Clin-ical DMPK", The Delaware Valley Drug Metabolism Discussion Group, February 11, 2010.
8. L.M. Patrone, "Direct Comparison of DBS Analysis to Plasma and Whole Blood Analysis in Toxicokinetic Studies of Rats," EBF Work-shop Connecting Strategies on Dried Blood Spots, June 17-18, 2010, Brussels, Belgium.
9. S.D. O'Broin and E.W. Gunter, The Ameri-can Journal of Clinical Nutrition 70(3), 359-367 (1999).
10. N. Spooner, R. Lad, and M. Barfield, Anal. Chem. 81(4), 1557-1563 (2009).
11. B. Ooms, "On-Line DBS-SPE-MS/MS: Feasibility of a Concept for Rapid DBS Analysis without Punching," EBF Work-shop Connecting Strategies on Dried Blood Spots, June 17-18, 2010, Brussels, Belgium.
12. M. Glinski, W Dobelin, and N. Ganz, "Fully Automated Direct Application of Dried Blood Spots Combined with HPLC Coupled to Tandem Mass Spectrometry for the Simul-taneous Quantification of Bosentan and its Metabolites," presented at Montreaux LC/MS 2010, November 10-12, 2010.
13. P. Abu-Rabie, "Direct Quantitative Bio-analysis of Drugs in Dried Blood Spot Sam-ples," EBF Workshop Connecting Strategies on Dried Blood Spots, June 17-18, 2010, Brussels, Belgium.
14. P. Abu-Rabie and N. Spooner, Anal.Chem. 81(24), 10275-10284 (2009).
15. F. Picard, C. Emotte, O. Heudi, T Majum-dar, W. Li, and M. Hayes, "An Overview of the Implementation of DBS at Novartis: Results and Next Step," Workshop Con-necting Strategies on Dried Blood Spots, June 17-18, 2010, Brussels, Belgium.
16. K.-S. Boos, private communication, December 17, 2010.
17. R. Morello, J. Milojkovic, and K.-S. Boos, Therapeutic Drug Monitoring29, 505 (2007).
18. R. Morello and K.-S. Boos, Separation Sci-ence Singapore 2010, Biopolis, August 5-6, 2010.
19. A.J. Wilhelm, J.C.G. den Burger, R.M. Vos, A. Chahbouni, and A. Sinjewel, J. Chro-matogr. B 877, 1595-1598 (2009).
20. J. Deglona, A. Thomasa, A. Cataldob, P. Mangina, and C. Staubam, J. Pharm. And Biomed. Analysis 49(4), 1034-1039 (2009).
21. W. Ayele, R. Schuurman, T Messele, W. Dorigo-Zetsma, Y. Mengistu, J. Goudsmit, WA. Paxton, M.P. de Baar, and G. Pollakis, J. Clinical Microbiol. 45(3), 891-896 (2007).
22. C. Smith, "Metabonomic Analysis of Dried Biofluid (Blood, Plasma, Urine) Spots", EBF Workshop Connecting Strategies on Dried Blood Spots, June 17-18, 2010, Brus-sels, Belgium.
23. M.F. Suyagh, G. Iheagwaram, P.L. Kole, J. Millership, P. Collier, H. Halliday, and J.C. McElnay, Anal. Bioanal. Chem. 397, 687-693 (2010).
24. M. Barfield, N. Spooner, R. Lad, S. Parry, and S. Fowles, J. Chromatogr. B 870, 32-37 (2008).
25. G.S. AbuRuz, J. Millership, and J. McElnay, J. Chromatogr. B 832(2), 202-207 (2006).
26. R.A. Thakur, M. Koleto, D. Dong, B. Beg-ley, and L. Koetzner, Current Trends in Mass Spectrometry (supplement to LCGC North America), 14-17 (October 2010).
27. B.R. Hoffman, H. Yu, and E.P. Diamandis, Clinical Chem. 42(4), 536-544 (1996).
28. R.S. Plumb, P.D. Rainville, and C.A. Evans, Current Trends in Mass Spectrom-etry (supplement to LCGC North America), 22-27 (July 2010).
29. S.J. Lehotay, M. Anastassiades, and R.E. Majors, LCGC North America 28(7), 504 (2010).
30. F. Plossl, M. Giera, and F. Bracher, J. Chromatogr. A 1135(1), 19-26 (2006).